You are here

Q: WHAT IS IMMUNOMODULATOR?

A: It is a medicine (not to be confused with dietary supplement) improving the effectiveness of immunodefences. It could have biologic, plant-based or synthetic origins. Its administration in treatment of a number of diseases may significantly accelerate recovery and minimize adverse effects. It can be of two types: immunomodulating and immunosuppressive. In this case, Licopid® 1 mg is an immunomodulator, which “helps” the immune system to recover and be ready to address the infection.

Q: IS LICOPID A MEDICINE?

A: Yes, it is. Licopid® is a medicine registered as such by the Ministry of Healthcare of the Russian Federation since 1995 (ls-001438-230911).

Q: IS IT HARMFUL TO USE DRUGS AFFECTING THE IMMUNE SYSTEM?

A: Licopid® 1 mg is a medicine and like other medicines has certain indications for use. If Licopid® is administered as indicated and in indicated dosages, it would not hurt but may help coping with situation above all.

Q: HOW LICOPID WORKS?

A: The effective agent of Licopid is a small molecule forming a part of a cell wall of all useful bifido- and lactic bacteria. It means that such substance is “known” to our body, and our body meets it daily. Licopid operates through receptor (relevant protein generally presented in different body cells) and normalizes operation of the first line of defense of our body, thereby helping to manage with recurrent respiratory and skin infections, frequent herpes recurrences.

Q: HOW LICOPID AFFECTS THE IMMUNE SYSTEM, IS IT SAFE?

A: It is safe since the effect of this drug is as close as possible to the natural immunoregulation process essentially evolved in all living organisms.

Q: HOW OFTEN SHOULD LICOPID BE ADMINISTERED?

A: It should be administered upon the emergence of indications for use indicated in the drug instruction. Moreover, Licopid 1 mg could be used for prevention and reduction of seasonal acute respiratory infections morbidity and frequency of exacerbations of recurrent diseases, upper and lower respiratory diseases, especially, during autumn-winter period.

Q: IS IT TRUE THAT LICOPID 1MG COULD ALSO BE USED BY ADULTS?

A: Yes, it is. Licopid 1 mg is indicated for treatment in different daily and course dosages in children over 3 years old and adults.

Q: WHAT IS PERORAL AND SUBLINGUAL USE?

A: Peroral administration is drug intake by swallowing it with water. Sublingual administration is dissolving a drug sublingually or in oral cavity without swallowing.

Q: IN WHAT CASES SHOULD LICOPID BE TAKEN SUBLIGUALLY?

A: In terms of Licopod 1 mg, sublingual use is indicated in most cases. More detailed information could be found in instruction on medical use of Licopid 1 mg in section “Nosology and method of administration” (“Nosology and administration”).

Q: WHETHER ANY PRECLINICAL AND CLINICAL STUDIES ON LICOPID 1 MG HAVE BEEN CARRIED OUT?

A: Preclinical and clinical studies have been carried out in Great Britain, Latvia, Australia, and Russia. Clinical studies have been carried out with patient randomization and placebo-control.

Q: WHETHER LICOPID 1MG COULD BE USED IN COMBINATION WITH OTHER MEDICINES?

A: Licopid could be used with a lot of medicines. However, Licopid must not be combined with glucocorticoids and must be taken not earlier than 1.5-2 hours after administration of adsorbents (activated carbon, and etc.).

Q: HOW LICOPID IS DISTINGUISHED FROM OTHER DIFFERENT IMMUNOMODULATORS?

A: Firstly, Licopid® 1 mg is a broad spectrum immunomodulator; it is effective against agents of bacterial, fungal, and viral origins. Secondly, it has known mechanism of action at molecular level.

Q: HOW FAST THIS DRUG STARTS WORKING?

A: After taking of the first tablet.